HyP-1 (50 μL, 0.3 mg/kg) was administered to tumor-bearing mice intravenously via tail vein injection, and PA images of both the tumor-bearing and control flanks were acquired at 1, 3, and 5 h following injection. This evidence concerns the gene PHEX and neoplasm.